• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • Navigate Novartis
    • Patients
    • Healthcare Professionals
    • Media
    • Investors
    • Partners
    • ESG
    • Job Seekers
    • Clinical Trials
  • Coronavirus
  • Global
    • Novartis site directory
Novartis logo: a global healthcare company
  • Our Company
    • Our Leadership
      • Board of Directors
      • Executive Committee of Novartis
    • Our Approach
      • Strategy
      • Corporate Responsibility
      • Diversity & Inclusion
      • Partnering
      • People and Culture
    • Our Business
      • Global Product Portfolio
      • Innovative Medicines
      • Novartis Pharmaceuticals
      • Novartis Gene Therapies
      • Novartis Oncology
      • Sandoz
    • Media
      • Newsroom
      • News Archive
      • Multimedia Resources
      • Subscribe to Updates
    • Investors
      • Event Calendar
      • Financial Data
      • Share Data & Analysis
      • Shareholder Information
      • Environmental, Social & Governance
  • Our Focus
    • Disease Areas
      • Cancer
      • Cardiovascular, Renal and Metabolic Medicine
      • Immunology & Dermatology
      • Ophthalmology
      • Neuroscience
      • Respiratory
    • Platforms and Technology
      • Data and Digital
      • Cell & Gene Therapy
    • Novartis Stories
      • Discovery
      • From Our Labs
      • Access to Healthcare
      • Patient Perspectives
      • People and Culture
      • Live Magazine
  • Our Impact
    • Building Trust with Society
      • Corporate Responsibility
      • Ethical Standards
      • Access
      • Environmental Sustainability
    • Global Health
      • Malaria
      • Sickle Cell Disease
      • Chagas disease
      • Leprosy
      • Novartis Foundation
    • ESG Performance and Reporting
      • Materiality Assessment
      • Environmental, Social and Governance
      • Transparency and Disclosures
      • Positions on Key Topics
      • Statements on Key Issues
  • Our Science
    • Research & Early Development
      • Novartis Institutes for BioMedical Research
      • Research Disease Areas
      • Postdoc Program
      • Open Source Science
    • Drug Development at Novartis
      • Novartis Pipeline
      • Clinical Trials
      • Translational Medicine
      • Global Product Portfolio
    • Science Stories
      • Discovery
      • From Our Labs
  • Careers
    • Your Career
      • Global Career Search
      • Teams and Skills
      • Gene Therapies Careers
    • Working at Novartis
      • Diversity & Inclusion
      • People and Culture
      • Corporate Responsibility
    • Career Programs
      • Our Career Programs
      • Students and Scholars
      • Novartis Quantitative Sciences Hackathon
Search
A “swell” discovery on how cells keep in shape - hero image
  • TwitterTweet
  • FacebookShare
  • Share
    • Twitter
    • Facebook
    • LinkedIn
    • Email
    • Whatsapp
  • Jump to Comments
Stories/Discovery

A “swell” discovery on how cells keep in shape

Cells have mechanical components.  Learn how GNF studies cell membranes to figure out what makes them tick.

Apr 11, 2014

An important finding published in the journal Cell adds insight to a 30-year mystery about how cells sense their environment, and could translate into help for diseases where water balance and cell volume are key, such as diabetes and stroke.

Our cells are constantly in a state of flux, working to maintain equilibrium to keep them alive. For instance, their membranes are permeable to water, which means that as water levels in their local environment change, so too does their internal concentration of ions, such as chloride, potassium, and sodium. Ion channels embedded in the membrane must pay close attention to their environment to determine when to open and close to maintain balance.

In the case of one type of ion channel called the volume-regulated anion channel, or VRAC, the important factor is cell swelling. When a cell’s environment is challenged with more water, for example, it begins to swell until, at some point before it bursts, it simply stops. It does so because, as the cell expands, VRAC pores open up and allow negatively charged ions to pass through the cell membrane.

The protein was first shown to exist in the 1980s, but the details of its function and its molecular identity have remained an enigma. So when ZhaoZhu Qiu joined Ardem Patapoutian's lab as a postdoctoral fellow at the Genomics Institute of the Novartis Research Foundation (GNF) looking for a good challenge, VRAC seemed like the perfect candidate. The Patapoutian lab is interested in the general question of how mechanical forces translate into biochemical signals, and GNF’s expertise in technology and high-throughput screens was critical in enabling this explorative project. Qiu spent the next four years working to uncover the molecular identity of VRAC.

"It is a fundamental biological process that has been studied for many years without any molecular insights. The identification of Swell1 I think will enable in-depth understanding of this basic cellular process" said Qiu.

Read more

GNF joins forces with New Yorker cartoonist for Cell cover

A “Swell” discovery on how cells keep in shape

The Cell cover illustration depicts a normal and a swollen cell as artworks in a museum: one small and dwarfed by a dense, wrinkly frame and the other large and smooth. The cover was designed by the illustrator Jorge Colombo using finger painting on an iPad. The GNF scientists admired his work in the New Yorker and contacted him to illustrate their paper in Cell about how cells sense their environment.

 

 

 

Tags: 
Novartis Institutes for BioMedical Research
    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • LinkedIn
      • Email
      • Whatsapp
    • Jump to Comments
  • Print
  • Save

Novartis Stories

View all

RNA strand
Discovery

Take a visual tour of medicines that target RNA

A kidney patient is smiling at the camera
Discovery

New hope for treating inflammatory diseases of the kidney

2D rendering of kidneys
Discovery

Predictive analytics could bring medicines to patients faster

You are here

  1. Home ›
  2. Stories ›
  3. Discovery

Novartis Global

  • Navigate Novartis

    • Patients & Caregivers
    • Healthcare Professionals
    • Investors
    • Media
    • Society & ESG
    • Partners
  • Contact Us

    • Global Contacts
    • Office Locations
    • For Investors
    • For Media
  • About Novartis

    • Our Company
    • Our Focus
    • Our Impact
    • Our Science
    • Our Stories
  • Our Portfolio

    • Global Product Portfolio
    • Global Clinical Pipeline
  • Careers

    • Career Search

Connect with Novartis

  • twitter
  • linkedin
  • youtube
  • facebook
  • instagram
Novartis Site Directory
© 2021 Novartis AG
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Site Map
  • Cookie Settings

This site is intended for a global audience.